Stay updated on Cabozantinib in Solid Tumors & HIV Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.

Latest updates to the Cabozantinib in Solid Tumors & HIV Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision label v3.5.4 was added, replacing the previous v3.5.3. This reflects a minor update to the page’s revision/version information.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page footer/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a documentation or platform release rather than a change to the trial details.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded Revision: v3.4.3; Removed Revision: v3.4.2.SummaryDifference0.0%

- Check106 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no changes to trial content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Solid Tumors & HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.